Tracking retatrutide potency across batches from the same supplier builds a quality history that informs your purchasing decisions and provides evidence of consistent supply for institutional reporting purposes
Approved Uses of Semaglutide Semaglutide was first approved for treating type 2 diabetes
Retatrutides triple-action effect targeting GLP-1, GIP, and glucagon can help keep weight off, raise metabolism, and help with other health markers
In the U.S., about 6% of adults currently use GLP-1s, and 12% have used them in the past (2024 data) (Mozafariun 2025)
Free to use, no sign-up just keep the visible credit link
Given that the glucose-lowering effect of metformin is so strong and is independent of incretin signalling, it might be difficult to detect the beneficial effect of metformin on the incretin axis in human studies